oxophenylarsine has been researched along with Basophilic Leukemia, Acute in 2 studies
oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumada, T | 1 |
| Nakashima, S | 1 |
| Miyata, H | 1 |
| Nozawa, Y | 1 |
| Massol, P | 1 |
| Montcourrier, P | 1 |
| Guillemot, JC | 1 |
| Chavrier, P | 1 |
2 other studies available for oxophenylarsine and Basophilic Leukemia, Acute
| Article | Year |
|---|---|
Potent activation of phospholipase D by phenylarsine oxide in rat basophilic leukemia (RBL-2H3) cells.
Topics: Animals; Arsenicals; Benzoquinones; Calcium; Cell Line; Enzyme Activation; Genistein; Isoflavones; K | 1994 |
Fc receptor-mediated phagocytosis requires CDC42 and Rac1.
Topics: Animals; Arsenicals; Bacterial Proteins; Bacterial Toxins; cdc42 GTP-Binding Protein; Cell Cycle Pro | 1998 |